Hiroyuki Ohta Selected Research

Galactolipids

9/2019	Lipid remodeling under acidic conditions and its interplay with low Pi stress in Arabidopsis.
1/2015	An engineered lipid remodeling system using a galactolipid synthase promoter during phosphate starvation enhances oil accumulation in plants.
1/2013	Role of galactolipid biosynthesis in coordinated development of photosynthetic complexes and thylakoid membranes during chloroplast biogenesis in Arabidopsis.
12/2009	Arabidopsis lipins mediate eukaryotic pathway of lipid metabolism and cope critically with phosphate starvation.
6/2009	Type A and type B monogalactosyldiacylglycerol synthases are spatially and functionally separated in the plastids of higher plants.
7/2006	Membrane lipid alteration during phosphate starvation is regulated by phosphate signaling and auxin/cytokinin cross-talk.
3/2005	A novel phosphatidylcholine-hydrolyzing phospholipase C induced by phosphate starvation in Arabidopsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Ohta Research Topics

Disease

21	Starvation 01/2021 - 02/2004
6	Neoplasms (Cancer) 04/2021 - 07/2006
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 05/2014
4	Rheumatoid Arthritis 12/2017 - 10/2011
4	Wounds and Injuries (Trauma) 02/2017 - 11/2005
4	Hypothermia 12/2010 - 03/2007
3	Infections 01/2021 - 11/2005
3	Neoplasm Metastasis (Metastasis) 11/2016 - 05/2014
3	Hypertension (High Blood Pressure) 03/2013 - 07/2009
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 07/2006
2	Joint Diseases (Joint Disease) 12/2017 - 10/2011
2	Ischemia 04/2016 - 05/2009
2	Inflammation (Inflammations) 01/2016 - 03/2007
2	Neuroinflammatory Diseases 01/2016 - 12/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2014 - 10/2011
2	Heart Failure 08/2010 - 07/2009
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2009 - 05/2009
1	Nematode Infections 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Sigmoid Neoplasms 01/2021
1	Multiple Sclerosis 12/2019
1	Malnutrition (Nutritional Deficiencies) 09/2019
1	Hemorrhage 06/2019
1	Atherosclerosis 12/2017
1	Huntington Disease (Huntington's Disease) 01/2017
1	Hypotension (Low Blood Pressure) 11/2016
1	Erythema 04/2016
1	Pyomyositis 04/2016

Drug/Important Bio-Agent (IBA)

15	Phosphates (Orthophosphate)IBA 01/2021 - 02/2004
8	Phosphorus (Red Phosphorus)IBA 10/2020 - 07/2006
8	Phospholipids (Phosphatides)FDA LinkGeneric 09/2019 - 03/2005
7	GalactolipidsIBA 09/2019 - 03/2005
6	Membrane LipidsIBA 10/2020 - 07/2006
6	LipidsIBA 09/2019 - 01/2009
5	Neuroprotective AgentsIBA 04/2016 - 03/2007
3	NitrogenIBA 01/2021 - 01/2017
3	digalactosyldiacylglycerolIBA 09/2019 - 03/2005
3	Methotrexate (Mexate)FDA LinkGeneric 12/2017 - 10/2011
3	1,2-diacylglycerol 3-beta-galactosyltransferase (monogalactosyldiacylglycerol synthase)IBA 01/2015 - 02/2004
3	DiglyceridesIBA 01/2015 - 07/2006
3	jasmonic acid (jasmonate)IBA 12/2014 - 11/2005
3	tocilizumab (atlizumab)FDA Link 05/2014 - 10/2011
3	SaltsIBA 03/2013 - 07/2009
3	Indoleacetic Acids (Auxin)IBA 03/2010 - 07/2006
2	CarbonIBA 01/2021 - 01/2019
2	AcidsIBA 09/2019 - 12/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 08/2014
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 01/2015
2	monogalactosyldiacylglycerolIBA 01/2017 - 01/2009
2	Oxygen (Dioxygen)IBA 11/2016 - 04/2016
2	CytokinesIBA 01/2016 - 05/2009
2	Dietary PhosphorusIBA 01/2016 - 07/2014
2	2-(2'-pyridyldithio)benzyldiazoacetateIBA 01/2016 - 12/2014
2	12-oxophytodienoic acidIBA 01/2016 - 11/2005
2	OxylipinsIBA 01/2016 - 12/2014
2	Biomarkers (Surrogate Marker)IBA 08/2015 - 07/2006
2	EnzymesIBA 01/2015 - 12/2009
2	Acyl Coenzyme A (Acyl CoA)IBA 01/2015 - 08/2014
2	AcyltransferasesIBA 01/2015 - 08/2014
2	Messenger RNA (mRNA)IBA 01/2014 - 05/2009
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2013 - 07/2009
2	ChlorophyllIBA 01/2013 - 07/2011
2	CytokininsIBA 06/2009 - 07/2006
2	Proteins (Proteins, Gene)FDA Link 05/2009 - 10/2008
2	Amino Acids FDA Link 09/2008 - 02/2008
1	IntegrasesIBA 04/2021
1	Keratins (Keratin)IBA 04/2021
1	VimentinIBA 04/2021
1	NitratesIBA 01/2021
1	Spermidine SynthaseIBA 01/2021
1	LigninIBA 01/2021
1	Ribulose-Bisphosphate Carboxylase (Rubisco)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	AnticoagulantsIBA 01/2021
1	SesquiterpenesIBA 01/2021
1	ProcalcitoninIBA 01/2021
1	suberinIBA 01/2021
1	PeroxidasesIBA 01/2021
1	Fatty Acid DesaturasesIBA 01/2021
1	flavanone synthetase (chalcone synthase)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 10/2020
1	Protons (Proton)IBA 09/2019
1	Fondaparinux (Arixtra)FDA Link 06/2019
1	fibrin fragment D (D-dimer)IBA 06/2019
1	Enoxaparin (Lovenox)FDA LinkGeneric 06/2019
1	CeruleninIBA 01/2019
1	CholesterolIBA 12/2017
1	tofacitinibIBA 12/2017
1	Janus Kinase InhibitorsIBA 12/2017
1	jasmonoyl-isoleucineIBA 02/2017
1	Phosphatidic Acids (Phosphatidic Acid)IBA 01/2017
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	lipineIBA 01/2017
1	PhosphatidylglycerolsIBA 01/2017
1	Linezolid (Zyvox)FDA Link 04/2016

Therapy/Procedure

5	Therapeutics 01/2021 - 03/2007
3	Hyperthermic Intraperitoneal Chemotherapy 11/2016 - 05/2014
1	Colectomy 01/2021
1	Gastrectomy 01/2021